Spitzer, A Robert, Broadman, Melissa · Pain practice : the official journal of World Institute of Pain · 2010 · DOI
Researchers looked at 118 patients with ME/CFS or fibromyalgia who had sleep problems similar to narcolepsy. When these patients were treated with a medication called sodium oxybate, 75% reported significant improvement in fatigue and 60% reported significant improvement in pain. This suggests that fixing the underlying sleep disorder might help relieve both conditions.
This study offers a novel mechanistic explanation for ME/CFS and fibromyalgia as sleep-related disorders and identifies a potential targeted treatment. The high response rate to sodium oxybate suggests that sleep architecture dysfunction may be central to these conditions, potentially opening new therapeutic pathways for patients with limited current treatment options.
This study does not prove that sodium oxybate causes symptom improvement, only that improvement was observed after treatment. It does not establish that all ME/CFS or fibromyalgia patients have narcolepsy-like disorders, nor does it prove that CFS and FM are the same disease. The lack of a control group means placebo effect and natural variation cannot be ruled out.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.